@article{Abraham_2021,
  author    = {Allistair A. Abraham and John F. Tisdale},
  journal   = {Blood},
  title     = {{Gene therapy for sickle cell disease: moving from the bench to the bedside}},
  year      = {2021},
  month     = {jul},
  number    = {11},
  pages     = {932--941},
  volume    = {138},
  doi       = {10.1182/blood.2019003776},
  publisher = {American Society of Hematology},
  url       = {https://doi.org/10.1182%2Fblood.2019003776}
}
  
@article{Aguilera_Cobos_2022,
  author    = {Lorena Aguilera-Cobos and Mar{\'{\i}}a Piedad Rosario-Lozano and Angela Ponce-Polo and Juan Antonio Blasco-Amaro and David Epstein},
  journal   = {Health Policy},
  title     = {{Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice: Umbrella review}},
  year      = {2022},
  month     = {dec},
  number    = {12},
  pages     = {1248--1255},
  volume    = {126},
  doi       = {10.1016/j.healthpol.2022.10.007},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.healthpol.2022.10.007}
}

@article{Alhakamy_2021,
  author    = {Alhakamy, Nabil A. and Curiel, David T. and Berkland, Cory J.},
  journal   = {Drug Discovery Today},
  title     = {{The era of gene therapy: From preclinical development to clinical application}},
  year      = {2021},
  issn      = {1359-6446},
  month     = {Jul},
  number    = {7},
  pages     = {1602-1619},
  volume    = {26},
  doi       = {10.1016/j.drudis.2021.03.021},
  publisher = {Elsevier BV},
  url       = {http://dx.doi.org/10.1016/j.drudis.2021.03.021}
}

@article{Allen_2023,
  author    = {Jeremy Allen and Diane Berry and Francesca Cook and Ashley Hume and Rayne Rouce and Anirudh Srirangam and Jennifer Wellman and Caitlin McCombs},
  journal   = {Molecular Therapy - Methods & Clinical Development},
  title     = {{Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions}},
  year      = {2023},
  month     = {jun},
  pages     = {513--521},
  volume    = {29},
  doi       = {10.1016/j.omtm.2023.05.015},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.omtm.2023.05.015}
}

@article{Arabi_2022,
  author    = {Fatemeh Arabi and Vahid Mansouri and Naser Ahmadbeigi},
  journal   = {Biomedicine & Pharmacotherapy},
  title     = {{Gene therapy clinical trials, where do we go? An overview}},
  year      = {2022},
  month     = {sep},
  pages     = {113324},
  volume    = {153},
  doi       = {10.1016/j.biopha.2022.113324},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.biopha.2022.113324}
}

@article{Avard_2002,
  doi       = {10.1053/spen.2002.30342},
  url       = {https://doi.org/10.1053%2Fspen.2002.30342},
  year      = {2002},
  month     = {mar},
  publisher = {Elsevier {BV}},
  volume    = {9},
  number    = {1},
  pages     = {53--61},
  author    = {Denise M. Avard and Bartha M. Knoppers},
  title     = {{Ethical dimensions of genetics in pediatric neurology: A look into the future}},
  journal   = {Seminars in Pediatric Neurology}
}

@article{Baas_2023,
  author    = {Lieke Baas and Rieke van der Graaf and Evelien S. van Hoorn and Annelien L. Bredenoord and Karina Meijer},
  journal   = {Journal of Thrombosis and Haemostasis},
  title     = {{The ethics of gene therapy for hemophilia: a narrative review}},
  year      = {2023},
  month     = {mar},
  number    = {3},
  pages     = {413--420},
  volume    = {21},
  doi       = {10.1016/j.jtha.2022.12.027},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jtha.2022.12.027}
}


@article{Barlow_2019,
  title     = {{Are Payers Ready, Willing, and Able to Provide Access to New Durable Gene Therapies?}},
  volume    = {22},
  issn      = {1098-3015},
  url       = {http://dx.doi.org/10.1016/j.jval.2018.12.004},
  doi       = {10.1016/j.jval.2018.12.004},
  number    = {6},
  journal   = {Value in Health},
  publisher = {Elsevier BV},
  author    = {Barlow, Jane F. and Yang, Mo and Teagarden, J. Russell},
  year      = {2019},
  month     = {Jun},
  pages     = {642–647}
}

@article{Canfield_2021,
  author    = {Canfield, Scott L},
  journal   = {American Journal of Health-System Pharmacy},
  title     = {{Decoding gene therapy: Current impact and future considerations for health-system and specialty pharmacy practice}},
  year      = {2021},
  issn      = {1535-2900},
  month     = {Mar},
  number    = {11},
  pages     = {953-961},
  volume    = {78},
  doi       = {10.1093/ajhp/zxab064},
  publisher = {Oxford University Press (OUP)},
  url       = {http://dx.doi.org/10.1093/ajhp/zxab064}
}

@article{Carvalho_2017,
  title     = {{Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework}},
  volume    = {4},
  issn      = {2296-858X},
  url       = {http://dx.doi.org/10.3389/fmed.2017.00182},
  doi       = {10.3389/fmed.2017.00182},
  journal   = {Frontiers in Medicine},
  publisher = {Frontiers Media SA},
  author    = {Carvalho, Marta and Sepodes, Bruno and Martins, Ana Paula},
  year      = {2017},
  month     = {Oct}
}

@article{Carvalho_2020,
  author    = {Carvalho, Marta and Sepodes, Bruno and Martins, Ana Paula},
  journal   = {BMJ Innovations},
  title     = {{Patient access to gene therapy medicinal products: a comprehensive review}},
  year      = {2020},
  issn      = {2055-642X},
  month     = {Oct},
  number    = {1},
  pages     = {123-134},
  volume    = {7},
  doi       = {10.1136/bmjinnov-2020-000425},
  publisher = {BMJ},
  url       = {http://dx.doi.org/10.1136/bmjinnov-2020-000425}
}

@article{Charlton_2021,
  title     = {{Does NICE apply the rule of rescue in its approach to highly specialised technologies?}},
  volume    = {48},
  issn      = {1473-4257},
  url       = {http://dx.doi.org/10.1136/medethics-2020-106759},
  doi       = {10.1136/medethics-2020-106759},
  number    = {2},
  journal   = {Journal of Medical Ethics},
  publisher = {BMJ},
  author    = {Charlton, Victoria},
  year      = {2021},
  month     = {Mar},
  pages     = {118–125}
}

@article{Chen_2023,
  author    = {Wenjia Chen and Yi Wang and Yaroslava Zemlyanska and Dimple Butani and Nigel Chong Boon Wong and Suchin Virabhak and David Bruce Matchar and Yot Teerawattananon},
  journal   = {Value in Health},
  title     = {{Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges}},
  year      = {2023},
  month     = {may},
  doi       = {10.1016/j.jval.2023.05.001},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2023.05.001}
}


@article{Colasante_2018,
  author    = {W Colasante},
  journal   = {Value in Health},
  title     = {{PMU75 - Is adopting a low price strategy to gain market
               access compatible with a viable gene/cell therapy business?}},
  year      = {2018},
  month     = {oct},
  pages     = {S320},
  volume    = {21},
  doi       = {10.1016/j.jval.2018.09.1911},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2018.09.1911}
}



@article{Coyle_2020,
  title     = {{HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies}},
  volume    = {21},
  issn      = {1618-7601},
  url       = {http://dx.doi.org/10.1007/s10198-020-01212-w},
  doi       = {10.1007/s10198-020-01212-w},
  number    = {9},
  journal   = {The European Journal of Health Economics},
  publisher = {Springer Science and Business Media LLC},
  author    = {Coyle, Doug and Durand-Zaleski, Isabelle and Farrington, Jasmine and Garrison, Louis and Graf von der Schulenburg, Johann-Matthias and Greiner, Wolfgang and Longworth, Louise and Meunier, Aurélie and Moutié, Anne-Sophie and Palmer, Stephen and Pemberton-Whiteley, Zack and Ratcliffe, Mark and Shen, Jie and Sproule, Doug and Zhao, Kun and Shah, Koonal},
  year      = {2020},
  month     = {Aug},
  pages     = {1421–1437}
}


@article{Cuende_2022,
  author    = {Natividad Cuende and Rachele Ciccocioppo and Miguel Forte and Jacques Galipeau and Laertis Ikonomou and Bruce L. Levine and Alok Srivastava and Patricia J. Zettler},
  journal   = {Cytotherapy},
  title     = {{Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products}},
  year      = {2022},
  month     = {jul},
  number    = {7},
  pages     = {686--690},
  volume    = {24},
  doi       = {10.1016/j.jcyt.2022.03.007},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jcyt.2022.03.007}
}

@article{Dabbous_2020,
  title     = {{Managed Entry Agreements: Policy Analysis From the European Perspective}},
  volume    = {23},
  issn      = {1098-3015},
  url       = {http://dx.doi.org/10.1016/j.jval.2019.12.008},
  doi       = {10.1016/j.jval.2019.12.008},
  number    = {4},
  journal   = {Value in Health},
  publisher = {Elsevier BV},
  author    = {Dabbous, Monique and Chachoua, Lylia and Caban, Aleksandra and Toumi, Mondher},
  year      = {2020},
  month     = {Apr},
  pages     = {425–433}
}

@article{Detela_2019,
  title     = {{EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation}},
  volume    = {13},
  issn      = {2329-0501},
  url       = {http://dx.doi.org/10.1016/j.omtm.2019.01.010},
  doi       = {10.1016/j.omtm.2019.01.010},
  journal   = {Molecular Therapy - Methods & Clinical Development},
  publisher = {Elsevier BV},
  author    = {Detela, Giulia and Lodge, Anthony},
  year      = {2019},
  month     = {Jun},
  pages     = {205–232}
}

@article{Drago_2021,
  author    = {Daniela Drago and Betsy Foss-Campbell and Keith Wonnacott and David Barrett and Adora Ndu},
  journal   = {Molecular Therapy - Methods & Clinical Development},
  title     = {{Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs}},
  year      = {2021},
  month     = {jun},
  pages     = {524--529},
  volume    = {21},
  doi       = {10.1016/j.omtm.2021.04.001},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.omtm.2021.04.001}
}

@article{Drummond_2019,
  author    = {Michael F. Drummond and Peter J. Neumann and Sean D. Sullivan and Frank-Ulrich Fricke and Sean Tunis and Omar Dabbous and Mondher Toumi},
  journal   = {Value in Health},
  title     = {{Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy}},
  year      = {2019},
  month     = {jun},
  number    = {6},
  pages     = {661--668},
  volume    = {22},
  doi       = {10.1016/j.jval.2019.03.012},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2019.03.012}
}

@article{Ermacora_2020,
  author    = {P. Ermacora and D. Meszarosova and A.D. Ong and D. Carr},
  journal   = {Value in Health},
  title     = {{PBI 47 - Innovative Approaches for Patient Access to Gene Therapies in Haemophilia}},
  year      = {2020},
  month     = {dec},
  pages     = {S418},
  volume    = {23},
  doi       = {10.1016/j.jval.2020.08.125},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2020.08.125}
}

@article{Fischer_2023,
  doi       = {10.1016/j.hlpt.2023.100744},
  url       = {https://doi.org/10.1016%2Fj.hlpt.2023.100744},
  year      = {2023},
  month     = {jun},
  publisher = {Elsevier {BV}},
  volume    = {12},
  number    = {2},
  pages     = {100744},
  author    = {Piret Fischer and Thomas Reiss and Jörg Mahlich and Erwan Gicquel and Heike Aichinger and Liliya Pullmann and Tanja Bratan},
  title     = {{Unlocking the value of innovative medicines: Insights from the advanced therapy medicinal products ({ATMP}) innovation systems in Germany and Sweden}},
  journal   = {Health Policy and Technology}
}

@article{Fox_2023,
  author    = {Fox, Thomas and Bueren, Juan and Candotti, Fabio and Fischer, Alain and Aiuti, Alessandro and Lankester, Arjan and Albert, Michael and Bernardo, Maria Ester and Cavazzana, Marina and Ehl, Stephan and Neven, Benedicte and Prevot, Johan and Schambach, Axel and Sevilla, Julian and Thrasher, Adrian and Wynn, Rob and Booth, Claire},
  journal   = {Nature Medicine},
  title     = {{Access to gene therapy for rare diseases when commercialization is not fit for purpose}},
  year      = {2023},
  issn      = {1546-170X},
  month     = {Feb},
  doi       = {10.1038/s41591-023-02208-8},
  publisher = {Springer Science and Business Media LLC},
  url       = {http://dx.doi.org/10.1038/s41591-023-02208-8}
}

@article{Gonçalves_2021,
  title     = {{Value-based pricing for advanced therapy medicinal products: emerging affordability solutions}},
  volume    = {23},
  issn      = {1618-7601},
  url       = {http://dx.doi.org/10.1007/s10198-021-01276-2},
  doi       = {10.1007/s10198-021-01276-2},
  number    = {2},
  journal   = {The European Journal of Health Economics},
  publisher = {Springer Science and Business Media LLC},
  author    = {Gonçalves, Elisabete},
  year      = {2021},
  month     = {Jun},
  pages     = {155–163}
}

@article{Grosvenor_2019,
  author    = {A. Grosvenor and P. Ermacora},
  journal   = {Value in Health},
  title     = {{PBI -19 Gene therapies: how will indication-based pricing affect patient access and cost-containment mechanisms for payers?}},
  year      = {2019},
  month     = {nov},
  pages     = {S420},
  volume    = {22},
  doi       = {10.1016/j.jval.2019.09.123},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2019.09.123}
}

@article{Hampson_2018,
  title     = {{Gene therapy: evidence, value and affordability in the US health care system}},
  volume    = {7},
  issn      = {2042-6313},
  url       = {http://dx.doi.org/10.2217/cer-2017-0068},
  doi       = {10.2217/cer-2017-0068},
  number    = {1},
  journal   = {Journal of Comparative Effectiveness Research},
  publisher = {Becaris Publishing Limited},
  author    = {Hampson, Grace and Towse, Adrian and Pearson, Steven D and Dreitlein, William B and Henshall, Chris},
  year      = {2018},
  month     = {Jan},
  pages     = {15–28}
}

@article{Hanna_2018,
  title     = {{Funding breakthrough therapies: A systematic review and recommendation}},
  volume    = {122},
  issn      = {0168-8510},
  url       = {http://dx.doi.org/10.1016/j.healthpol.2017.11.012},
  doi       = {10.1016/j.healthpol.2017.11.012},
  number    = {3},
  journal   = {Health Policy},
  publisher = {Elsevier BV},
  author    = {Hanna, E. and Toumi, M. and Dussart, C. and Borissov, B. and Dabbous, O. and Badora, K. and Auquier, P.},
  year      = {2018},
  month     = {Mar},
  pages     = {217–229}
}

@article{Horgan_2020,
  title     = {{Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion}},
  volume    = {5},
  issn      = {2296-6870},
  url       = {http://dx.doi.org/10.1159/000511678},
  doi       = {10.1159/000511678},
  number    = {3},
  journal   = {Biomedicine Hub},
  publisher = {S. Karger AG},
  author    = {Horgan, Denis and Metspalu, Andres and Ouillade, Marie-Christine and Athanasiou, Dimitrios and Pasi, John and Adjali, Oumeya and Harrison, Patrick and Hermans, Cedric and Codacci-Pisanelli, Giovanni and Koeva, Jasmina and Szucs, Thomas and Cursaru, Viorica and Belina, Ivica and Bernini, Chiara and Zhuang, Suijie and McMahon, Stephen and Toncheva, Draga and Thum, Thomas},
  year      = {2020},
  month     = {Dec},
  pages     = {1–23}
}

@article{Iskrov_2019,
  author    = {Iskrov, Georgi and Vasilev, Georgi and Stefanov, Rumen},
  journal   = {Expert Opinion on Orphan Drugs},
  title     = {{What could gene therapies learn from orphan drugs' post-regulatory approval access in the EU?}},
  year      = {2019},
  issn      = {2167-8707},
  month     = {Sep},
  number    = {9},
  pages     = {407-414},
  volume    = {7},
  doi       = {10.1080/21678707.2019.1663171},
  publisher = {Informa UK Limited},
  url       = {http://dx.doi.org/10.1080/21678707.2019.1663171}
}

@article{Jørgensen_2017,
  title     = {{Annuity payments can increase patient access to innovative cell and gene therapies under England’s net budget impact test}},
  volume    = {5},
  issn      = {2001-6689},
  url       = {http://dx.doi.org/10.1080/20016689.2017.1355203},
  doi       = {10.1080/20016689.2017.1355203},
  number    = {1},
  journal   = {Journal of Market Access & Health Policy},
  publisher = {Informa UK Limited},
  author    = {Jørgensen, Jesper and Kefalas, Panos},
  year      = {2017},
  month     = {Jan},
  pages     = {1355203}
}
  
@article{Jørgensen_2020,
  title     = {{Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries}},
  volume    = {8},
  issn      = {2001-6689},
  url       = {http://dx.doi.org/10.1080/20016689.2020.1715536},
  doi       = {10.1080/20016689.2020.1715536},
  number    = {1},
  journal   = {Journal of Market Access & Health Policy},
  publisher = {Informa UK Limited},
  author    = {Jørgensen, Jesper and Hanna, Eve and Kefalas, Panos},
  year      = {2020},
  month     = {Jan},
  pages     = {1715536}
}

@article{Jørgensen_2021,
  title     = {{The use of innovative payment mechanisms for gene therapies in Europe and the USA}},
  volume    = {16},
  issn      = {1746-076X},
  url       = {http://dx.doi.org/10.2217/rme-2020-0169},
  doi       = {10.2217/rme-2020-0169},
  number    = {4},
  journal   = {Regenerative Medicine},
  publisher = {Future Medicine Ltd},
  author    = {Jørgensen, Jesper and Kefalas, Panos},
  year      = {2021},
  month     = {Apr},
  pages     = {405–422}
}

@article{Kearns_2021,
  author    = {Lisa Kearns and Carolyn Riley Chapman and Kenneth I. Moch and Arthur L. Caplan and Tom Watson and Andrew McFadyen and Pat Furlong and Alison Bateman-House},
  journal   = {Molecular Therapy},
  title     = {{Gene therapy companies have an ethical obligation to develop expanded access policies}},
  year      = {2021},
  month     = {apr},
  number    = {4},
  pages     = {1367--1369},
  volume    = {29},
  doi       = {10.1016/j.ymthe.2021.03.008},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.ymthe.2021.03.008}
}

@article{Kirmani_2023,
  author    = {Salman Kirmani and Fizza Akbar and Arif Mehboobali and Sidra Kaleem},
  journal   = {Genetics in Medicine Open},
  title     = {{P214: Experience in delivering free of cost gene therapy for spinal muscular atrophy using the managed access program in Pakistan}},
  year      = {2023},
  number    = {1},
  pages     = {100242},
  volume    = {1},
  doi       = {10.1016/j.gimo.2023.100242},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.gimo.2023.100242}
}

@article{Mansnérus_2015,
  title     = {{Encountering Challenges with the eu Regulation on Advance Therapy Medical Products}},
  volume    = {22},
  issn      = {1571-8093},
  url       = {http://dx.doi.org/10.1163/15718093-12341369},
  doi       = {10.1163/15718093-12341369},
  number    = {5},
  journal   = {European Journal of Health Law},
  publisher = {Brill},
  author    = {Mansnérus, Juli},
  year      = {2015},
  month     = {Oct},
  pages     = {426–461}
}

@article{Marusakova_2018,
  author    = {E Marusakova and M Vulganova},
  journal   = {Value in Health},
  title     = {{PND110 - Gene therapy products - market access situation in eu and in slovakia}},
  year      = {2018},
  month     = {oct},
  pages     = {S347},
  volume    = {21},
  doi       = {10.1016/j.jval.2018.09.2076},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2018.09.2076}
}

@article{McKie_2003,
  title    = {{The Rule of Rescue}},
  volume   = {56},
  issn     = {02779536},
  url      = {https://linkinghub.elsevier.com/retrieve/pii/S0277953602002447},
  doi      = {10.1016/S0277-9536(02)00244-7},
  number   = {12},
  journal  = {Social Science & Medicine},
  author   = {McKie, John and Richardson, Jeff},
  year     = {2003},
  month    = {jun},
  pages    = {2407–2419},
  language = {en}
}

@article{Meyer_2022,
  author    = {M Meyer-Acs and L Loke and M Esser},
  journal   = {Value in Health},
  title     = {{HTA - 177 Current Developments in the Market Access Conditions for Gene Therapies in Germany}},
  year      = {2022},
  month     = {dec},
  number    = {12},
  pages     = {S331},
  volume    = {25},
  doi       = {10.1016/j.jval.2022.09.1635},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2022.09.1635}
}

@article{Mitrei_2023,
  doi       = {10.1016/j.reth.2023.06.003},
  url       = {https://doi.org/10.1016%2Fj.reth.2023.06.003},
  year      = {2023},
  month     = {dec},
  publisher = {Elsevier {BV}},
  volume    = {24},
  pages     = {74--77},
  author    = {Dinko Mitre{\v{c}}i{\'{c}}},
  title     = {{Is it enough just to demonstrate that the advanced therapy medicinal products do work or we would prefer to keep walking on the Moon?}},
  journal   = {Regenerative Therapy}
}

@article{Montazerhodjat_2016,
  title     = {{Buying cures versus renting health: Financing health care with consumer loans}},
  volume    = {8},
  issn      = {1946-6242},
  url       = {http://dx.doi.org/10.1126/scitranslmed.aad6913},
  doi       = {10.1126/scitranslmed.aad6913},
  number    = {327},
  journal   = {Science Translational Medicine},
  publisher = {American Association for the Advancement of Science (AAAS)},
  author    = {Montazerhodjat, Vahid and Weinstock, David M. and Lo, Andrew W.},
  year      = {2016},
  month     = {Feb}
}

@article{Mycka_2022a,
  author    = {Mycka, J and Dalal, N and Dellamano, R},
  journal   = {Value in Health},
  title     = {{HPR149 Global Pricing, Reimbursement and Market Access Trends for Regenerative Medicines, ATMPs, Cell, & Gene Therapies}},
  year      = {2022},
  issn      = {1098-3015},
  month     = {Dec},
  number    = {12},
  pages     = {S259},
  volume    = {25},
  doi       = {10.1016/j.jval.2022.09.1278},
  publisher = {Elsevier BV},
  url       = {http://dx.doi.org/10.1016/j.jval.2022.09.1278}
}

@article{Mycka_2022b,
  author    = {Mycka, J and Dellamano, R and Lobb, W and Dalal, N and Pollere, D},
  journal   = {Value in Health},
  title     = {{HPR26 - Pricing, Reimbursement and Market Access Trends for Cell and Gene Therapies in the US and Europe}},
  year      = {2022},
  issn      = {1098-3015},
  month     = {Jul},
  number    = {7},
  pages     = {S471},
  volume    = {25},
  doi       = {10.1016/j.jval.2022.04.952},
  publisher = {Elsevier BV},
  url       = {http://dx.doi.org/10.1016/j.jval.2022.04.952}
}

@article{Neuhaus_2018,
  author    = {Carolyn P. Neuhaus and Rachel L. Zacharias},
  journal   = {Seminars in Perinatology},
  title     = {{Compassionate use of gene therapies in pediatrics: An ethical analysis}},
  year      = {2018},
  month     = {dec},
  number    = {8},
  pages     = {508--514},
  volume    = {42},
  doi       = {10.1053/j.semperi.2018.09.010},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1053%2Fj.semperi.2018.09.010}
}

@article{Noone_2020,
  title     = {{Reimbursing the value of gene therapy care in an era of uncertainty}},
  volume    = {27},
  issn      = {1365-2516},
  url       = {http://dx.doi.org/10.1111/hae.14218},
  doi       = {10.1111/hae.14218},
  number    = {1},
  journal   = {Haemophilia},
  publisher = {Wiley},
  author    = {Noone, Declan and Coffin, Donna and Pierce, Glenn F.},
  year      = {2020},
  month     = {Nov},
  pages     = {12–18}
}

@article{Overbeeke_2021,
  author    = {van Overbeeke, Eline and Michelsen, Sissel and Toumi, Mondher and Stevens, Hilde and Trusheim, Mark and Huys, Isabelle and Simoens, Steven},
  journal   = {Drug Discovery Today},
  title     = {{Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions}},
  year      = {2021},
  issn      = {1359-6446},
  month     = {Feb},
  number    = {2},
  pages     = {399-415},
  volume    = {26},
  doi       = {10.1016/j.drudis.2020.11.024},
  publisher = {Elsevier BV},
  url       = {http://dx.doi.org/10.1016/j.drudis.2020.11.024}
}

@article{Pimenta_2021,
  title     = {{Advanced Therapies and Regulatory Framework in Different Areas of the Globe: Past, Present, and Future}},
  volume    = {43},
  issn      = {0149-2918},
  url       = {http://dx.doi.org/10.1016/j.clinthera.2021.02.006},
  doi       = {10.1016/j.clinthera.2021.02.006},
  number    = {5},
  journal   = {Clinical Therapeutics},
  publisher = {Elsevier BV},
  author    = {Pimenta, Cleila and Bettiol, Vitória and Alencar-Silva, Thuany and Franco, Octavio Luiz and Pogue, Robert and Carvalho, Juliana Lott and Felipe, Maria Sueli Soares},
  year      = {2021},
  month     = {May},
  pages     = {e103–e138}
}

@article{Polak_2021,
  author    = {Tobias B. Polak and Eline M. Bunnik},
  journal   = {Molecular Therapy},
  title     = {{Financial considerations in expanded access policy for gene therapies: A tough nut to crack?}},
  year      = {2021},
  month     = {jun},
  number    = {6},
  pages     = {1936},
  volume    = {29},
  doi       = {10.1016/j.ymthe.2021.04.030},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.ymthe.2021.04.030}
}

@article{Rmuzat_2015,
  author    = {C{\'{e}}cile R{\'{e}}muzat and Mondher Toumi and Jesper J{\o}rgensen and Panos Kefalas},
  journal   = {Journal of Market Access & Health Policy},
  title     = {{Market access pathways for cell therapies in France}},
  year      = {2015},
  month     = {jan},
  number    = {1},
  pages     = {29094},
  volume    = {3},
  doi       = {10.3402/jmahp.v3.29094},
  publisher = {Informa {UK} Limited},
  url       = {https://doi.org/10.3402%2Fjmahp.v3.29094}
}

@article{Sabatini_2022,
  author    = {Sabatini, Marco T. and Xia, Tia and Chalmers, Mark},
  journal   = {Pharmaceutical Medicine},
  title     = {{Pricing and Market Access Challenges in the Era of One-Time Administration Cell and Gene Therapies}},
  year      = {2022},
  issn      = {1179-1993},
  month     = {Aug},
  number    = {5},
  pages     = {265-274},
  volume    = {36},
  doi       = {10.1007/s40290-022-00443-x},
  publisher = {Springer Science and Business Media LLC},
  url       = {http://dx.doi.org/10.1007/s40290-022-00443-x}
}

@article{Salzman_2018,
  title     = {{Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments}},
  volume    = {26},
  issn      = {1525-0016},
  url       = {http://dx.doi.org/10.1016/j.ymthe.2018.10.017},
  doi       = {10.1016/j.ymthe.2018.10.017},
  number    = {12},
  journal   = {Molecular Therapy},
  publisher = {Elsevier BV},
  author    = {Salzman, Rachel and Cook, Francesca and Hunt, Timothy and Malech, Harry L. and Reilly, Philip and Foss-Campbell, Betsy and Barrett, David},
  year      = {2018},
  month     = {Dec},
  pages     = {2717–2726}
}

@article{Sherman_2018,
  author    = {Sherman, Michael},
  journal   = {Nature},
  title     = {{Access and affordability for all}},
  year      = {2018},
  issn      = {1476-4687},
  month     = {Dec},
  number    = {7735},
  pages     = {S23-S23},
  volume    = {564},
  doi       = {10.1038/d41586-018-07648-8},
  file      = {:Sherman_2018 - Access and Affordability for All.pdf:PDF},
  publisher = {Springer Science and Business Media LLC},
  url       = {http://dx.doi.org/10.1038/d41586-018-07648-8}
}


@article{Sopena_2020,
  author    = {L. Sopena and B. English and R. Munetsi},
  journal   = {Value in Health},
  title     = {{PBI - 48 Overview of gene therapy pricing policies and reimbursement models in the EU-5 (Germany, UK, France, Italy and Spain)}},
  year      = {2020},
  month     = {dec},
  pages     = {S418},
  volume    = {23},
  doi       = {10.1016/j.jval.2020.08.126},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2020.08.126}
}

@article{TenHam_2022,
  title     = {{Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England}},
  volume    = {25},
  issn      = {1098-3015},
  url       = {http://dx.doi.org/10.1016/j.jval.2021.09.012},
  doi       = {10.1016/j.jval.2021.09.012},
  number    = {3},
  journal   = {Value in Health},
  publisher = {Elsevier BV},
  author    = {Ten Ham, Renske M.T. and Frederix, Geert W.J. and Wu, Olivia and Goettsch, Wim and Leufkens, Hubert G.M. and Klungel, Olaf H. and Hoekman, Jarno},
  year      = {2022},
  month     = {Mar},
  pages     = {390–399}
}

@article{Thielen_2022,
  author    = {Frederick W. Thielen and Renaud J.S.D. Heine and Sibren van den Berg and Renske M. T. ten Ham and Carin A. Uyl-de Groot},
  journal   = {Cytotherapy},
  title     = {{Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma}},
  year      = {2022},
  month     = {dec},
  number    = {12},
  pages     = {1245--1258},
  volume    = {24},
  doi       = {10.1016/j.jcyt.2022.09.002},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jcyt.2022.09.002}
}

@article{Tunis_2021,
  author    = {Sean Tunis and Eve Hanna and Peter J. Neumann and Mondher Toumi and Omar Dabbous and Michael Drummond and Frank-Ulrich Fricke and Sean D. Sullivan and Daniel C. Malone and Ulf Persson and James D. Chambers},
  journal   = {Health Policy},
  title     = {{Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe}},
  year      = {2021},
  month     = {dec},
  number    = {12},
  pages     = {1550--1556},
  volume    = {125},
  doi       = {10.1016/j.healthpol.2021.10.003},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.healthpol.2021.10.003}
}

@article{Tzaras_2020,
  author    = {D. Tzaras and D. Carr},
  journal   = {Value in Health},
  title     = {{PBI - 52 Ensuring Patient Access to Gene Therapies: The Role of Companion Diagnostics}},
  year      = {2020},
  month     = {dec},
  pages     = {S419},
  volume    = {23},
  doi       = {10.1016/j.jval.2020.08.130},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2020.08.130}
}

@article{Vellekoop_2022,
  author    = {Heleen Vellekoop and Matthijs Versteegh and Simone Huygens and Isaac Corro Ramos and L{\'{a}}szl{\'{o}} Szilberhorn and Tam{\'{a}}s Zelei and Bal{\'{a}}zs Nagy and Apostolos Tsiachristas and Rositsa Koleva-Kolarova and Sarah Wordsworth and Maureen Rutten-van Mölken},
  journal   = {Value in Health},
  title     = {{The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis}},
  year      = {2022},
  month     = {aug},
  number    = {8},
  pages     = {1428--1438},
  volume    = {25},
  doi       = {10.1016/j.jval.2022.01.006},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jval.2022.01.006}
}

@article{White_2019,
  author    = {White, Wendy},
  journal   = {Gene Therapy},
  title     = {{A rare disease patient/caregiver perspective on fair pricing and access to gene-based therapies}},
  year      = {2019},
  issn      = {1476-5462},
  month     = {Nov},
  number    = {10-11},
  pages     = {474-481},
  volume    = {27},
  doi       = {10.1038/s41434-019-0110-7},
  publisher = {Springer Science and Business Media LLC},
  url       = {http://dx.doi.org/10.1038/s41434-019-0110-7}
}

@article{Wirth_2013,
  title     = {{History of gene therapy}},
  volume    = {525},
  issn      = {0378-1119},
  url       = {http://dx.doi.org/10.1016/j.gene.2013.03.137},
  doi       = {10.1016/j.gene.2013.03.137},
  number    = {2},
  journal   = {Gene},
  publisher = {Elsevier BV},
  author    = {Wirth, Thomas and Parker, Nigel and Ylä-Herttuala, Seppo},
  year      = {2013},
  month     = {Aug},
  pages     = {162–169}
}

@article{Zettler_2023,
  author    = {Patricia J. Zettler and Laertis Ikonomou and Aaron D. Levine and Leigh Turner and Bambi Grilley and Beth E. Roxland},
  journal   = {Cytotherapy},
  title     = {{An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies}},
  year      = {2023},
  month     = {jul},
  number    = {7},
  pages     = {712--717},
  volume    = {25},
  doi       = {10.1016/j.jcyt.2023.02.004},
  publisher = {Elsevier {BV}},
  url       = {https://doi.org/10.1016%2Fj.jcyt.2023.02.004}
}

@misc{eu_mechanism,
  howpublished = {\url{https://www.ema.europa.eu/en/human-regulatory/overview/support-early-access}},
  note         = {Accessed: 2023-06-29},
  publisher    = {{European Medicines Agency (EMA)}},
  title        = {{Support for early access | European Medicines Agency}}
}

@misc{Regulation_1394,
  title     = {{Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004}},
  url       = {https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex:32007R1394},
  publisher = {{The Official Journal of the European Union}}
}

@misc{Directive_83,
  title     = {{Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use}},
  publisher = {{The Official Journal of the European Union}},
  url       = {https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02001L0083-20220101}
}

@article{Celis_2010,
  title     = {{CAT – The new committee for advanced therapies at the European Medicines Agency}},
  volume    = {53},
  issn      = {1437-1588},
  url       = {http://dx.doi.org/10.1007/s00103-009-0998-y},
  doi       = {10.1007/s00103-009-0998-y},
  number    = {1},
  journal   = {Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz},
  publisher = {Springer Science and Business Media LLC},
  author    = {Celis, P.},
  year      = {2010},
  month     = {jan},
  pages     = {9–13}
}

@article{Kondo_2019,
  title     = {{Regulatory/Scientific Supports for Micro-, Small-, and Medium-Sized Enterprises (SMEs) With Medicinal Products Provided by the PMDA and EMA}},
  volume    = {53},
  issn      = {2168-4804},
  url       = {http://dx.doi.org/10.1177/2168479018771312},
  doi       = {10.1177/2168479018771312},
  number    = {2},
  journal   = {Therapeutic Innovation &; Regulatory Science},
  publisher = {Springer Science and Business Media LLC},
  author    = {Kondo, Hideyuki and Shibatsuji, Masayoshi and Yasuda, Naoyuki},
  year      = {2019},
  month     = {mar},
  pages     = {193–198}
}

@misc{MPHMA,
  title     = {{Medicinal Products in Human Medicine Act}},
  year      = {2007},
  publisher = {State Gazette}
}

@misc{Ordinance_10,
  title     = {{Ordinance No. 10 (17/11/2011) on the conditions and procedure for the treatment with medicinal products not authorised for use in the Republic of Bulgaria, medicinal products administered outside the terms of the authorisation for use and medicinal products for compassionate use, as well as on the conditions and procedure for the inclusion, modification, exclusion and supply of medicinal products from the list referred to in article 266a, paragraph 2 of Medicinal Products in Human Medicine Act (suppl. - sg 84/1929, suppl. - sg 40/2022)}},
  year      = {2022},
  publisher = {State Gazette}
}

@mics{Ordinance_34,
  title     = {{Ordinance No. 34 (25/11/2005) on the procedure for payment from the state budget for the treatment of bulgarian citizens for diseases outside the scope of compulsory health insurance (amended, sg no. 65/2018)}},
  year      = {2018},
  publisher = {State Gazette}
}

@mics{Ordinance_2,
  title     = {{Ordinance No. 2 (27/3/20219) on the medical and other services referred to in article 82, paragraphs 1a and 3 of the health act and the procedure for their approval, use and payment}},
  year      = {2019},
  publisher = {State Gazette}
}

@mics{Ordinance,
  title     = {{Ordinance on the conditions, rules and procedure for regulating and registering the prices of medicinal products (suppl. - sg 97/2013)}},
  year      = {2013},
  publisher = {State Gazette}
}

@article{Ferrario_2015,
  title     = {{Dealing with uncertainty and high prices of new medicines: A comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden}},
  volume    = {124},
  issn      = {0277-9536},
  url       = {http://dx.doi.org/10.1016/j.socscimed.2014.11.003},
  doi       = {10.1016/j.socscimed.2014.11.003},
  journal   = {Social Science & Medicine},
  publisher = {Elsevier BV},
  author    = {Ferrario, Alessandra and Kanavos, Panos},
  year      = {2015},
  month     = {jan},
  pages     = {39–47}
}


@article{Koleva_Kolarova_2022,
  title     = {{Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options}},
  volume    = {20},
  issn      = {1179-1896},
  url       = {http://dx.doi.org/10.1007/s40258-021-00714-9},
  doi       = {10.1007/s40258-021-00714-9},
  number    = {4},
  journal   = {Applied Health Economics and Health Policy},
  publisher = {Springer Science and Business Media LLC},
  author    = {Koleva-Kolarova, Rositsa and Buchanan, James and Vellekoop, Heleen and Huygens, Simone and Versteegh, Matthijs and Mölken, Maureen Rutten-van and Szilberhorn, László and Zelei, Tamás and Nagy, Balázs and Wordsworth, Sarah and Tsiachristas, Apostolos},
  year      = {2022},
  month     = {apr},
  pages     = {501–524}
}

@article{Djambazov_2022,
  title     = {{HPR30 Reimbursement Pathway for Advanced Therapy Medicinal Products in Bulgaria}},
  volume    = {25},
  issn      = {1098-3015},
  url       = {http://dx.doi.org/10.1016/j.jval.2022.04.956},
  doi       = {10.1016/j.jval.2022.04.956},
  number    = {7},
  journal   = {Value in Health},
  publisher = {Elsevier BV},
  author    = {Djambazov, S and Vutova, Y and Dacheva, A and Koleva-Kolarova, R and Encheva-Malinova, M},
  year      = {2022},
  month     = {jul},
  pages     = {S472}
}

@article{Cornetta_2018,
  title     = {{Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy}},
  volume    = {26},
  issn      = {1525-0016},
  url       = {http://dx.doi.org/10.1016/j.ymthe.2018.11.002},
  doi       = {10.1016/j.ymthe.2018.11.002},
  number    = {12},
  journal   = {Molecular Therapy},
  publisher = {Elsevier BV},
  author    = {Cornetta, Kenneth and Patel, Kirtika and Wanjiku, Christopher Mwaniki and Busakhala, Naftali},
  year      = {2018},
  month     = {dec},
  pages     = {2715–2716}
}

@article{Yl_Herttuala_2012,
  title     = {{The Need for Increased Clarity and Transparency in the Regulatory Pathway for Gene Medicines in the European Union}},
  volume    = {20},
  issn      = {1525-0016},
  url       = {http://dx.doi.org/10.1038/mt.2012.14},
  doi       = {10.1038/mt.2012.14},
  number    = {3},
  journal   = {Molecular Therapy},
  publisher = {Elsevier BV},
  author    = {Ylä-Herttuala, Seppo},
  year      = {2012},
  month     = {mar},
  pages     = {471–472}
}

@article{Kerpel_Fronius_2020,
  title     = {{Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society}},
  volume    = {7},
  issn      = {2296-858X},
  url       = {http://dx.doi.org/10.3389/fmed.2020.608249},
  doi       = {10.3389/fmed.2020.608249},
  journal   = {Frontiers in Medicine},
  publisher = {Frontiers Media SA},
  author    = {Kerpel-Fronius, Sandor and Baroutsou, Varvara and Becker, Sander and Carlesi, Roberto and Collia, Luis and Franke-Bray, Brigitte and Kleist, Peter and Kurihara, Chieko and Laranjeira, Luis Filipe and Matsuyama, Kotone and Naseem, Shehla and Schenk, Johanna and Silva, Honorio},
  year      = {2020},
  month     = {dec}
}

@article{Exadaktylos_2005,
  title     = {{Organisation and financing of the health care systems of Bulgaria and Greece – what are the parallels?}},
  volume    = {5},
  issn      = {1472-6963},
  url       = {http://dx.doi.org/10.1186/1472-6963-5-41},
  doi       = {10.1186/1472-6963-5-41},
  number    = {1},
  journal   = {BMC Health Services Research},
  publisher = {Springer Science and Business Media LLC},
  author    = {Exadaktylos, Nikolaos M},
  year      = {2005},
  month     = {may}
}

@article{Sharpe_2021,
  title     = {{Clinical Adoption of Advanced Therapies: Challenges and Opportunities}},
  volume    = {110},
  issn      = {0022-3549},
  url       = {http://dx.doi.org/10.1016/j.xphs.2020.08.027},
  doi       = {10.1016/j.xphs.2020.08.027},
  number    = {5},
  journal   = {Journal of Pharmaceutical Sciences},
  publisher = {Elsevier BV},
  author    = {Sharpe, Michaela and Barry, Jacqueline and Kefalas, Panos},
  year      = {2021},
  month     = {may},
  pages     = {1877–1884}
}

@article{Singer_2012,
  title     = {{Challenges and solutions for personalizing medicines}},
  volume    = {1},
  issn      = {2211-8837},
  url       = {http://dx.doi.org/10.1016/j.hlpt.2012.01.010},
  doi       = {10.1016/j.hlpt.2012.01.010},
  number    = {1},
  journal   = {Health Policy and Technology},
  publisher = {Elsevier BV},
  author    = {Singer, Donald R.J. and Marsh, Andrew},
  year      = {2012},
  month     = {mar},
  pages     = {50–57}
}

@article{Drummond_2021,
  title     = {{Performance-based risk-sharing agreements in renal care: current experience and future prospects}},
  volume    = {21},
  issn      = {1744-8379},
  url       = {http://dx.doi.org/10.1080/14737167.2021.1876566},
  doi       = {10.1080/14737167.2021.1876566},
  number    = {2},
  journal   = {Expert Review of Pharmacoeconomics & Outcomes Research},
  publisher = {Informa UK Limited},
  author    = {Drummond, Michael and Federici, Carlo and Busink, Ellen and Apel, Christian and Kendzia, Dana and Brouwer, Werner},
  year      = {2021},
  month     = {mar},
  pages     = {197–210}
}

@misc{GR_list,
  title  = {{Θετική Λίστα (Positive drug list)}},
  author = {{Υπουργείο Υγείας (Ministry of Health)}},
  year   = {2023},
  url    = {https://www.moh.gov.gr/articles/times-farmakwn/thetikh-lista}
}

@misc{Romania_list,
  title  = {{Lista medicamentelor compensate și gratuite (list of fully and partially reimbursed medicines)}},
  author = {{Casa Națională de Asigurări de Sănătate (National Health Insurance House)}},
  year   = {2023},
  url    = {https://www.cnas.ro/lista-medicamente/}
}

@misc{Bulgaria_list,
  title  = {{Позитивен лекарствен списък (Positive drug list)}},
  author = {{Национален съвет по цени и реимбурсиране (National Council on Prices and Reimbursement)}},
  year   = {2023},
  url    = {https://portal.ncpr.bg/registers/}
}

@misc{Romanian_bank,
  title  = {{Bancpost}},
  author = {{Banca Naciala a Romaniei (National Bank of Romania) - Exchange rates, daily series}},
  year   = {2023},
  url    = {https://www.bnr.ro/Exchange-rates-15192.aspx}
}


 @article{Yfantopoulos_2018,
  title     = {{Drug Policy in Greece}},
  volume    = {16},
  issn      = {2212-1099},
  url       = {http://dx.doi.org/10.1016/j.vhri.2018.06.006},
  doi       = {10.1016/j.vhri.2018.06.006},
  journal   = {Value in Health Regional Issues},
  publisher = {Elsevier BV},
  author    = {Yfantopoulos, John N. and Chantzaras, Athanasios},
  year      = {2018},
  month     = {sep},
  pages     = {66–73}
}


@article{Paveliu_2018,
  title     = {{PCP37 - The confidentiality regarding drugs pricing and reimbursement in Romania}},
  volume    = {21},
  issn      = {1098-3015},
  url       = {http://dx.doi.org/10.1016/j.jval.2018.09.512},
  doi       = {10.1016/j.jval.2018.09.512},
  journal   = {Value in Health},
  publisher = {Elsevier BV},
  author    = {Paveliu, M.S. and Radu, P.},
  year      = {2018},
  month     = oct,
  pages     = {S87}
}

@article{Kamusheva_2021,
  title     = {{Do Advanced Therapies Have a Future in the Low- and Middle-Income Countries - The Case of Bulgaria, Romania, and Poland}},
  volume    = {9},
  issn      = {2296-2565},
  url       = {http://dx.doi.org/10.3389/fpubh.2021.729847},
  doi       = {10.3389/fpubh.2021.729847},
  journal   = {Frontiers in Public Health},
  publisher = {Frontiers Media SA},
  author    = {Kamusheva, Maria and Turcu-Stiolica, Adina and Gierczyński, Jakub and Subtirelu, Mihaela-Simona and Czech, Marcin and Petrova, Guenka},
  year      = {2021},
  month     = {aug}
}

 @article{Pejcic_2018,
  title     = {{Access to orphan drugs – comparison across Balkan countries}},
  volume    = {122},
  issn      = {0168-8510},
  url       = {http://dx.doi.org/10.1016/j.healthpol.2018.04.009},
  doi       = {10.1016/j.healthpol.2018.04.009},
  number    = {6},
  journal   = {Health Policy},
  publisher = {Elsevier BV},
  author    = {Pejcic, Ana V. and Iskrov, Georgi and Jakovljevic, Mihajlo Michael and Stefanov, Rumen},
  year      = {2018},
  month     = {jun},
  pages     = {583–589}
}

@article{Iskrov_2019а,
  author    = {Georgi Iskrov, Georgi Vasilev and Rumen Stefanov},
  title     = {What could gene therapies learn from orphan drugs’ post-regulatory approval access in the EU?},
  journal   = {Expert Opinion on Orphan Drugs},
  volume    = {7},
  number    = {9},
  pages     = {407-414},
  year      = {2019},
  publisher = {Taylor & Francis},
  doi       = {10.1080/21678707.2019.1663171},
  url       = {https://doi.org/10.1080/21678707.2019.1663171},
  eprint    = {https://doi.org/10.1080/21678707.2019.1663171}
}

